These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11786517)

  • 1. Vascular origin of a soluble truncated form of the hepatocyte growth factor receptor (c-met).
    Wajih N; Walter J; Sane DC
    Circ Res; 2002 Jan; 90(1):46-52. PubMed ID: 11786517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells.
    Wajih N; Sane DC
    Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
    Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
    J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth.
    Cai W; Rook SL; Jiang ZY; Takahara N; Aiello LP
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1885-93. PubMed ID: 10845613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
    Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma.
    Dong G; Chen Z; Li ZY; Yeh NT; Bancroft CC; Van Waes C
    Cancer Res; 2001 Aug; 61(15):5911-8. PubMed ID: 11479233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
    Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms.
    Peña-Silva RA; Chalouhi N; Wegman-Points L; Ali M; Mitchell I; Pierce GL; Chu Y; Ballas ZK; Heistad D; Hasan D
    Hypertension; 2015 Mar; 65(3):587-93. PubMed ID: 25510828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor.
    Zlot C; Ingle G; Hongo J; Yang S; Sheng Z; Schwall R; Paoni N; Wang F; Peale FV; Gerritsen ME
    J Biol Chem; 2003 Nov; 278(48):47654-9. PubMed ID: 14500721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
    Xu KP; Yu FS
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
    Abounader R; Ranganathan S; Kim BY; Nichols C; Laterra J
    J Neurochem; 2001 Mar; 76(5):1497-508. PubMed ID: 11238734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic property of hepatocyte growth factor is dependent on upregulation of essential transcription factor for angiogenesis, ets-1.
    Tomita N; Morishita R; Taniyama Y; Koike H; Aoki M; Shimizu H; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
    Circulation; 2003 Mar; 107(10):1411-7. PubMed ID: 12642363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor triggers signaling cascades mediating vascular smooth muscle cell migration.
    Taher TE; Derksen PW; de Boer OJ; Spaargaren M; Teeling P; van der Wal AC; Pals ST
    Biochem Biophys Res Commun; 2002 Oct; 298(1):80-6. PubMed ID: 12379223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
    Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
    Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
    Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
    Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.
    Sanada F; Taniyama Y; Iekushi K; Azuma J; Okayama K; Kusunoki H; Koibuchi N; Doi T; Aizawa Y; Morishita R
    Circ Res; 2009 Sep; 105(7):667-75, 13 p following 675. PubMed ID: 19713535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor/scatter factor and MET are involved in arterial repair and atherogenesis.
    McKinnon H; Gherardi E; Reidy M; Bowyer D
    Am J Pathol; 2006 Jan; 168(1):340-8. PubMed ID: 16400035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.